30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Cascadian Therapeutics Inc (CASC)

Track

Stock chart
Ticker: CASC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Myers Scott Dunseth
President and CEO
1 purchase — total 20,543 USD
Buy 11 Aug 2017
Value US$787,834.10 | Price 493.32 | Shares 90,433
Buy 12 May 2017
Value US$2,385,324.09 | Price 244.64 | Shares 86,308
Buy 31 Mar 2017
Value US$8,228.60 | Price 4.11 | Shares 2,000
Buy 28 Mar 2017
Value US$6,856.92 | Price 4.12 | Shares 1,666
Buy 20 Mar 2017
Value US$3,927.10 | Price 3.93 | Shares 1,000
Buy 2 Feb 2017
Value US$97,520.00 | Price 4.24 | Shares 23,000
Buy 30 Jan 2017
Value US$103,972.75 | Price 4.11 | Shares 25,324
Buy 27 Jan 2017
Value US$77,039.00 | Price 3.76 | Shares 20,500
Buy 17 Aug 2016
Value US$51,745.50 | Price 1.15 | Shares 45,000
Buy 28 Jun 2016
Value US$50,000.00 | Price 0.80 | Shares 62,500
Buy 1 Jun 2015
Value US$26,723.55 | Price 4.65 | Shares 5,747
Buy 26 Mar 2015
Value US$15,856.00 | Price 1.59 | Shares 10,000
Buy 25 Mar 2015
Value US$16,271.00 | Price 1.63 | Shares 10,000
Buy 17 Dec 2014
Value US$95,661.92 | Price 1.73 | Shares 55,197
Buy 17 Dec 2014
Value US$170,360.26 | Price 1.73 | Shares 98,298
Buy 15 Dec 2014
Value US$149,248.54 | Price 1.88 | Shares 79,434
Buy 15 Dec 2014
Value US$273,408.13 | Price 1.88 | Shares 145,515
Buy 1 Nov 2013
Value US$141,260.80 | Price 1.78 | Shares 79,360
Buy 1 Nov 2013
Value US$88,359.20 | Price 1.78 | Shares 49,640
Buy 8 Aug 2013
Value US$293,512.03 | Price 1.65 | Shares 177,940
Buy 8 Aug 2013
Value US$132,654.44 | Price 1.65 | Shares 80,421
Buy 1 Aug 2013
Value US$63,651.31 | Price 1.78 | Shares 35,703
Buy 1 Aug 2013
Value US$218,644.37 | Price 1.78 | Shares 122,641
Buy 31 Jul 2013
Value US$307,306.61 | Price 1.71 | Shares 179,743
Sale 10 Jul 2013
Value US$5,853.50 | Price 1.72 | Shares 3,403
Buy 7 Jun 2013
Value US$76,009.19 | Price 1.83 | Shares 41,526
Buy 7 Jun 2013
Value US$136,778.47 | Price 1.83 | Shares 74,726
Buy 6 Jun 2013
Value US$48,768.17 | Price 1.78 | Shares 27,384
Buy 6 Jun 2013
Value US$98,895.16 | Price 1.78 | Shares 55,531
Buy 5 Jun 2013
Value US$8,750.00 | Price 1.75 | Shares 5,000
Buy 5 Jun 2013
Value US$18,025.00 | Price 1.75 | Shares 10,300
Sale 20 Feb 2013
Value US$25,053.91 | Price 1.96 | Shares 12,780
Sale 23 Jun 2011
Value US$252,586.00 | Price 8.74 | Shares 28,900
Buy 28 Sep 2010
Value US$17,410.89 | Price 3.41 | Shares 5,100
Buy 18 Aug 2009
Value US$18,796.00 | Price 5.08 | Shares 3,700
Buy 18 Aug 2009
Value US$507.00 | Price 5.07 | Shares 100
Buy 18 Aug 2009
Value US$6,060.00 | Price 5.05 | Shares 1,200
Buy 12 Feb 2008
Value US$13,000.00 | Price 2.60 | Shares 5,000
Buy 18 Jan 2008
Value US$8,054.50 | Price 1.81 | Shares 4,450
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-08-14 2017-08-11 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
90,433 -21.3%
493.32
US$787,834 		90,433 -21.3% 493.32 US$787,834
2017-05-16 2017-05-12 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
86,308 -33.1%
244.64
US$2,385,324 		86,308 -33.1% 244.64 US$2,385,324
2017-04-04 2017-03-31 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
52,874 -37.1%
163.82
US$4,597,688 		52,874 -37.1% 163.82 US$4,597,688
2017-03-30 2017-03-28 B Purchase Fyfe Gwen A.
1,666 +100.0%
4.12
US$6,857 		1,666 +100.0% 4.12 US$6,857
2017-03-21 2017-03-20 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
1,000 +2.6%
3.93
US$3,927 		1,000 +2.6% 3.93 US$3,927
2017-02-03 2017-02-02 B Purchase LOVE TED W Non-Executive Director
23,000 +546.4%
4.24
US$97,520 		23,000 +546.4% 4.24 US$97,520
2017-02-01 2017-01-30 B Purchase HENNEY CHRISTOPHER S Non-Executive Director
25,324 +102.6%
4.11
US$103,973 		25,324 +102.6% 4.11 US$103,973
2017-01-31 2017-01-27 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
20,500 +114.4%
3.76
US$77,039 		20,500 +114.4% 3.76 US$77,039
2016-08-18 2016-08-17 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
45,000 +72.0%
1.15
US$51,746 		45,000 +72.0% 1.15 US$51,746
2016-06-28 2016-06-28 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
62,500 +inf%
0.80
US$50,000 		62,500 +inf% 0.80 US$50,000
2015-06-03 2015-06-01 B Purchase HAUSMAN DIANA

Chief Medical Officer

Officer
5,747 +inf%
4.65
US$26,724 		5,747 +inf% 4.65 US$26,724
2015-04-01 2015-03-26 B Purchase SPIEGELMAN DANIEL K Non-Executive Director
10,000 +32.6%
1.59
US$15,856 		10,000 +32.6% 1.59 US$15,856
2015-04-01 2015-03-25 B Purchase SPIEGELMAN DANIEL K Non-Executive Director
10,000 +48.4%
1.63
US$16,271 		10,000 +48.4% 1.63 US$16,271
2014-12-17 2014-12-17 B Purchase BVF PARTNERS L P/IL Large shareholder
55,197 +1.7%
1.73
US$95,662 		55,197 +1.7% 1.73 US$95,662
2014-12-17 2014-12-17 B Purchase BVF PARTNERS L P/IL Large shareholder
98,298 +1.6%
1.73
US$170,360 		98,298 +1.6% 1.73 US$170,360
2014-12-17 2014-12-15 B Purchase BVF PARTNERS L P/IL Large shareholder
79,434 +2.5%
1.88
US$149,249 		79,434 +2.5% 1.88 US$149,249
2014-12-17 2014-12-15 B Purchase BVF PARTNERS L P/IL Large shareholder
145,515 +2.4%
1.88
US$273,408 		145,515 +2.4% 1.88 US$273,408
2013-11-05 2013-11-01 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
79,360 +3.1%
1.78
US$141,261 		79,360 +3.1% 1.78 US$141,261
2013-11-05 2013-11-01 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
49,640 +1.0%
1.78
US$88,359 		49,640 +1.0% 1.78 US$88,359
2013-08-12 2013-08-08 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
177,940 +7.4%
1.65
US$293,512 		177,940 +7.4% 1.65 US$293,512
2013-08-12 2013-08-08 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
80,421 +1.7%
1.65
US$132,654 		80,421 +1.7% 1.65 US$132,654
2013-08-02 2013-08-01 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
35,703 +1.5%
1.78
US$63,651 		35,703 +1.5% 1.78 US$63,651
2013-08-02 2013-08-01 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
122,641 +2.7%
1.78
US$218,644 		122,641 +2.7% 1.78 US$218,644
2013-08-02 2013-07-31 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
179,743 +4.1%
1.71
US$307,307 		179,743 +4.1% 1.71 US$307,307
2014-10-08 2013-07-10 S Sale SPIEGELMAN DANIEL K Non-Executive Director
3,403 -14.2%
1.72
US$5,854 		3,403 -14.2% 1.72 US$5,854
2013-06-07 2013-06-07 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
41,526 +1.8%
1.83
US$76,009 		41,526 +1.8% 1.83 US$76,009
2013-06-07 2013-06-07 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
74,726 +1.7%
1.83
US$136,778 		74,726 +1.7% 1.83 US$136,778
2013-06-07 2013-06-06 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
27,384 +1.2%
1.78
US$48,768 		27,384 +1.2% 1.78 US$48,768
2013-06-07 2013-06-06 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
55,531 +1.3%
1.78
US$98,895 		55,531 +1.3% 1.78 US$98,895
2013-06-07 2013-06-05 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
5,000 +0.2%
1.75
US$8,750 		5,000 +0.2% 1.75 US$8,750
2013-06-07 2013-06-05 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
10,300 +0.2%
1.75
US$18,025 		10,300 +0.2% 1.75 US$18,025
2014-10-08 2013-02-20 S Sale SPIEGELMAN DANIEL K Non-Executive Director
12,780 -34.7%
1.96
US$25,054 		12,780 -34.7% 1.96 US$25,054
2011-06-27 2011-06-23 S Sale Ayer Capital Management, LP Large shareholder
28,900 -1.0%
8.74
US$252,586 		28,900 -1.0% 8.74 US$252,586
2010-09-29 2010-09-28 B Purchase Karan Shashi K.

Corporate Controller

Officer
5,100 +102.0%
3.41
US$17,411 		5,100 +102.0% 3.41 US$17,411
2009-08-18 2009-08-18 B Purchase Karan Shashi K.

Corporate Controller

Officer
3,700 +284.6%
5.08
US$18,796 		3,700 +284.6% 5.08 US$18,796
2009-08-18 2009-08-18 B Purchase Karan Shashi K.

Corporate Controller

Officer
100 +8.3%
5.07
US$507 		100 +8.3% 5.07 US$507
2009-08-18 2009-08-18 B Purchase Karan Shashi K.

Corporate Controller

Officer
1,200 +inf%
5.05
US$6,060 		1,200 +inf% 5.05 US$6,060
2008-02-14 2008-02-12 B Purchase Jackson Richard L. Non-Executive Director
5,000 +inf%
2.60
US$13,000 		5,000 +inf% 2.60 US$13,000
2008-01-18 2008-01-18 B Purchase Taylor Edward A.

CFO, VP Fin Admin, Sec

Officer
4,450 +67.8%
1.81
US$8,054 		4,450 +67.8% 1.81 US$8,054
Explore more

More insider trading research around Cascadian Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America